nivolumab
bms
['opdivo', 'check,mate,76k', 'bristol', '$bmy']
bristol myers squibb presents data from checkmate -76k showing opdivo reduced the risk of recurrence or death by 58% versus placebo in patients with comp.. $bmy 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice